Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Zenzedi ® (dextroamphetamine sulfate tablets, USP) 30 mg Due to a Mislabeled Package During Manufacturing

Woburn, Massachusetts, Azurity Pharmaceuticals, Inc. is voluntarily recalling one (1) lot (F230169A) of Zenzedi ® CII (dextroamphetamine sulfate tablets, USP) 30 mg to the consumer level. The product is being recalled due to a report from a pharmacist in Nebraska who opened a bottle of Zenzedi® 30 m

Source: FDA Center for Drug Evaluation and Research - What's New - January 25, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news